RECURRENT NASOPHARYNX CARCINOMA
Clinical trials for RECURRENT NASOPHARYNX CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NASOPHARYNX CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NASOPHARYNX CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests a combination of three drugs—an EGFR antibody, a PD-1 inhibitor, and chemotherapy—in people whose nasopharyngeal cancer has come back or spread. The goal is to see if this mix can shrink tumors or delay growth better than current options. About 148 adults aged 18…
Matched conditions: RECURRENT NASOPHARYNX CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New combo therapy aims to control returning throat cancer
Disease control Recruiting nowThis study tests a treatment plan for people whose nasopharyngeal cancer has returned after initial therapy. Participants first receive a combination of immunotherapy (PD-1 inhibitor) and chemotherapy. Those who respond well are then randomly assigned to get either immediate re-i…
Matched conditions: RECURRENT NASOPHARYNX CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 19, 2026 11:59 UTC